Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kite Pharma
Kite Pharma
ASCO 2019 day two
Pharmaforum
Sun, 06/2/19 - 01:01 pm
Gilead Sciences
Kite Pharma
KTE-X19
CAR-T
ASCO 2019
Novartis
Merck
Keytruda
spartalizumab
5 Things You Can Expect for Gilead Sciences With Its New CEO at the Helm
Motley Fool
Sun, 05/5/19 - 10:34 am
Gilead Sciences
Daniel O'Day
M&A
Kite Pharma
filgotinib
Gilead's first move under new chief is to untether Kite
Biopharma Dive
Fri, 05/3/19 - 10:47 pm
Kite Pharma
Gilead Sciences
CAR-T
Daniel O'Day
Kite's CAR-T manufacturing gets another boost with new Maryland facility
Fierce Pharma
Wed, 04/24/19 - 04:07 pm
Gilead Sciences
Kite Pharma
drug manufacturing
Maryland
CAR-T
Gilead’s Kite pens 10-target CAR-T tech deal with MaxCyte
Fierce Biotech
Sat, 03/2/19 - 12:42 pm
Gilead Sciences
Kite Pharma
CAR-T
MaxCyte
Gilead drops anti-BCMA CAR-T from Kite, takes $820M charge
Fierce Biotech
Tue, 02/5/19 - 11:50 am
Gilead Sciences
Multiple Myeloma
Kite Pharma
anti-BCMA
Gilead’s Kite bags option to buy gamma delta startup Gadeta
Fierce Biotech
Thu, 07/19/18 - 11:17 am
Gilead Sciences
Kite Pharma
Gadeta
T-cell receptors
M&A
Kite Receives Positive Opinion from CHMP for Yescarta in Lymphoma
CP Wire
Fri, 06/29/18 - 09:50 am
Kite Pharma
Gilead Sciences
EMA
CHMP
Yescarta
B-cell lymphoma
Kite Receives Positive Opinion from CHMP for Yescarta in Lymphoma
Fri, 06/29/18 - 09:42 am
Kite Pharma
B cell lymphoma
Gilead: Did Biktarvy Kill The Sell Thesis?
Seeking Alpha
Tue, 03/27/18 - 09:54 am
Gilead Sciences
Biktarvy
HIV
Kite Pharma
Cell therapy flotations could follow Kite and Juno buyouts
EP Vantage
Wed, 03/7/18 - 06:24 pm
cell therapy
Kite Pharma
Juno Therapeutics
M&A
Unum Therapeutics
Autolus
Gilead Sciences: The Oncology Company?
Motley Fool
Mon, 02/26/18 - 10:27 am
Gilead Sciences
oncology
Kite Pharma
Cell Design Labs
Sangamo Therapeutics
Biotech sector ensures highest premium among M&A transactions
GoinPharma
Tue, 01/2/18 - 11:05 am
biotech
M&A
Kite Pharma
Gilead Sciences
JNJ
Actelion
Kymriah, Yescarta found ‘cost-effective’ in treating cancer, despite high price
Endpoints
Thu, 12/21/17 - 10:12 am
Kymriah
Yescarta
CAR-T
Novartis
Kite Pharma
Gilead Sciences
drug pricing
Deal of the Year: Gilead Buys Kite Pharma
BioPharma Dive
Mon, 12/4/17 - 09:39 am
Gilead Sciences
Kite Pharma
M&A
Gilead Slaps Mega-Price on Its Newly Approved CAR-T
Motley Fool
Fri, 10/20/17 - 09:04 am
Gilead Sciences
CAR-T
drug pricing
Yescarta
Kite Pharma
Move over, Novartis: Kite and Gilead break into CAR-T market with early axi-cel nod
Fierce Pharma
Thu, 10/19/17 - 09:12 am
Gilead Sciences
Kite Pharma
Novartis
CAR-T
FDA
axi-cel
Yescarta
non-Hodgkin's lymphoma
large B-cell lymphoma
Why Is Cash-Rich Gilead Sciences, Inc. Borrowing $3 Billion?
Motley Fool
Fri, 09/22/17 - 11:25 am
Gilead Sciences
taxes
Kite Pharma
M&A
New Guidelines Address CAR-T Immunotherapy Toxicities to Prevent Patient Deaths
Xtalks
Wed, 09/20/17 - 10:41 am
CAR-T
Juno Therapeutics
Kite Pharma
Cellectis
Gilead Sciences' Kite Pharma Deal Has Already Paid for Itself -- for Investors
Motley Fool
Tue, 09/19/17 - 08:46 am
Gilead Sciences
Kite Pharma
M&A
investors
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »